Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Corvallis › NPI 1962453134
Hospital

Good Samaritan Hospital Corvallis

Good Samaritan Hospital Corvallis was paid $14.58M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99284, emergency room visit (serious) — 48% of everything it billed.

33Billing provider infoGOOD SAMARITAN HOSPITAL CORVALLIS
CORVALLIS, OR 97330
33aNPI1962453134assigned 05/13/2006
28Total paid$14.58M
24GClaims246,773
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201829,242$1.82M
201930,042$1.80M
202025,059$1.33M
202137,564$2.11M
202244,132$2.66M
202337,262$2.34M
2024incomplete43,472$2.52M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 48% 24,633 22,314 $7.04M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 28% 20,954 18,933 $4.14M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.7% 5,581 5,059 $830K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 2,096 1,903 $738K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.3% 3,871 3,590 $486K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 4,617 4,131 $198K
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m <1% 3,408 825 $142K
71045 Radiologic examination, chest; single view <1% 1,456 1,300 $89K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,859 1,973 $71K
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity <1% 1,920 567 $67K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,917 1,830 $64K
88142 <1% 2,855 2,730 $63K
91 more codes
99223 Prolong inpt eval add15 m <1% 528 $55K
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes <1% 232 $52K
96375 Therapeutic injection; each additional sequential IV push <1% 956 $47K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,344 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,343 $42K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,183 $39K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 126 $38K
80053 Comprehensive metabolic panel <1% 36,098 $36K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 94 $33K
36415 Collection of venous blood by venipuncture <1% 39,200 $24K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 818 $22K
84443 Thyroid stimulating hormone (TSH) <1% 1,898 $21K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 151 $18K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 10,784 $15K
J7120 Ringers lactate infusion, up to 1000 cc <1% 712 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 619 $14K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 413 $13K
99238 Hospital discharge day management, 30 minutes or less <1% 223 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,579 $11K
99213 Doctor's office visit, returning patient (routine) <1% 211 $10K
80061 Lipid panel <1% 983 $10K
93296 <1% 1,188 $9K
99214 Doctor's office visit, returning patient (more involved) <1% 342 $8K
77336 <1% 99 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 138 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 788 $5K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 35 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 183 $4K
70450 Computed tomography, head or brain; without contrast material <1% 34 $4K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 137 $3K
81514 <1% 13 $3K
87522 Neg quan hep c or qual rna <1% 74 $3K
82274 <1% 165 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 115 $2K
99222 Initial hospital care, per day, moderate complexity <1% 24 $2K
71046 Radiologic examination, chest; 2 views <1% 31 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 474 $2K
99220 <1% 14 $2K
72110 <1% 27 $2K
85027 <1% 544 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 14 $2K
86780 <1% 147 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,616 $1K
86850 <1% 68 $1K
86803 <1% 73 $876.18
99239 Hospital discharge day management, more than 30 minutes <1% 13 $871.55
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 61 $765.05
A9270 Non-covered item or service <1% 3,852 $708.06
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 14 $698.54
96361 Intravenous infusion, hydration; each additional hour <1% 14 $688.61
93294 <1% 141 $546.53
94726 <1% 28 $542.17
87081 <1% 91 $462.11
82728 <1% 100 $439.23
86140 <1% 145 $419.01
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 30 $384.14
93248 <1% 91 $320.78
84481 <1% 14 $203.28
0298T <1% 85 $190.07
94729 <1% 33 $180.51
86704 <1% 17 $168.70
81001 <1% 13,413 $167.55
86709 <1% 17 $166.99
84439 <1% 28 $153.34
86706 <1% 17 $150.36
87340 <1% 17 $144.62
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 426 $89.26
94060 <1% 13 $84.54
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 531 $76.64
73030 <1% 14 $74.56
82247 <1% 15 $58.73
G0411 Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes <1% 71 $57.45
84703 <1% 949 $21.00
85652 <1% 16 $20.10
73140 <1% 19 $19.17
83690 <1% 4,078 $17.89
84484 <1% 1,299 $14.08
99024 0% 63 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 0% 98 $0.00
87077 0% 13 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 21 $0.00
80306 0% 453 $0.00
81003 0% 16 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 0% 242 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 25 $0.00
97803 0% 72 $0.00
81025 0% 55 $0.00
87186 0% 13 $0.00
76000 0% 19 $0.00
87210 0% 12 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOHNSON, JOSIAH (CEO - GSRMC)
Parent organizationGOOD SAMARITAN HOSPITAL CORVALLIS
Same official

Other billing entities under JOHNSON, JOSIAH

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.